Compare OGI & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OGI | OPRX |
|---|---|---|
| Founded | 2013 | 2006 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 218.5M | 222.6M |
| IPO Year | N/A | N/A |
| Metric | OGI | OPRX |
|---|---|---|
| Price | $1.56 | $10.82 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $19.67 |
| AVG Volume (30 Days) | ★ 813.8K | 300.9K |
| Earning Date | 02-10-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.00 |
| Revenue | ★ $186,075,713.00 | $109,506,000.00 |
| Revenue This Year | $20.38 | $19.77 |
| Revenue Next Year | $6.02 | $11.33 |
| P/E Ratio | ★ N/A | $5,970.49 |
| Revenue Growth | N/A | ★ 24.18 |
| 52 Week Low | $0.85 | $3.99 |
| 52 Week High | $2.24 | $22.25 |
| Indicator | OGI | OPRX |
|---|---|---|
| Relative Strength Index (RSI) | 39.25 | 39.09 |
| Support Level | $1.46 | $9.73 |
| Resistance Level | $1.64 | $11.91 |
| Average True Range (ATR) | 0.07 | 0.79 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 18.15 | 41.38 |
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.